On 7/24/24, Emergent BioSolutions Inc (NYSE: EBS) stock enjoyed a major increase of 10.6%, closing at $13.81. Moreover, above average trading volume at 137% of normal accompanied the advance. Relative to the market the stock has been exceptionally strong over the last nine months and has risen 14.0% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to be above the cost of capital, EBS is expected to be a major Value Builder.
Emergent BioSolutions has a current Value Trend Rating of A (Highest Rating). This rating combines inconsistent signals from two proprietary PTR measures of a stock’s attractiveness. Emergent BioSolutions has a neutral Appreciation Score of 49 but a very high Power Rating of 100, with the Highest Value Trend Rating the result.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of A. This review will be completed in the next several days.
Be the first to comment